Last synced on 14 November 2025 at 11:06 pm

HYDRASHIFT 2/4 daratumumab, daratumumab Control

Page Type
Cleared 510(K)
510(k) Number
K172195
510(k) Type
Traditional
Applicant
Sebia
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
1/11/2018
Days to Decision
174 days
Submission Type
Summary

HYDRASHIFT 2/4 daratumumab, daratumumab Control

Page Type
Cleared 510(K)
510(k) Number
K172195
510(k) Type
Traditional
Applicant
Sebia
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
1/11/2018
Days to Decision
174 days
Submission Type
Summary